Koken Ltd. (TYO:7963)
1,719.00
+15.00 (0.88%)
Aug 1, 2025, 3:30 PM JST
Koken Revenue
Koken had revenue of 2.83B JPY in the quarter ending March 31, 2025, with 16.65% growth. This brings the company's revenue in the last twelve months to 11.17B, up 11.24% year-over-year. In the year 2024, Koken had annual revenue of 10.76B with 1.65% growth.
Revenue (ttm)
11.17B
Revenue Growth
+11.24%
P/S Ratio
0.76
Revenue / Employee
34.79M
Employees
321
Market Cap
8.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.76B | 175.00M | 1.65% |
Dec 31, 2023 | 10.59B | -17.00M | -0.16% |
Dec 31, 2022 | 10.60B | 401.00M | 3.93% |
Dec 31, 2021 | 10.20B | 51.00M | 0.50% |
Dec 31, 2020 | 10.15B | 1.55B | 17.98% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.22B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,480.25B |
HOYA Corporation | 866.03B |
Otsuka Holdings | 2,393.18B |
Terumo | 1,036.17B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |